In this video, we will look at key considerations for oligo therapeutic developers entering the market, such as scalability, flexibility, regulatory concerns, insource/outsource considerations, and security of supply. You will learn about:
- the oligonucleotide therapeutic market
- the therapeutics in development
- challenges you may face and key considerations to address those challenges
- how to scale up manufacturing
